A STUDY OF OBINUTUZUMAB (RO5072759) PLUS CHEMOTHERAPY IN COMPARISON WITH RITUXIMAB PLUS CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB OR RITUXIMAB MAINTENANCE IN PATIENTS WITH UNTREATED ADVANCED INDOLENT NON-HODGKIN'S LYMPHOMA (GALLIUM):